PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'From the, Covid19 Department, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.\', \'Internal Medicine Department, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.\', \'Microbiology and Infectious Diseases Division, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.\', \'Ophtalmology Department, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.\', \'CIBEREHD.\', \'Pulmonary Medicine Department, Clinica Universidad de Navarra, Pamplona, Navarra, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/joim.13156
?:hasPublicationType
?:journal
  • Journal of internal medicine
is ?:pmid of
?:pmid
?:pmid
  • 32729633
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.042
?:rankingScore_hIndex
  • 140
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all